ACOR
Acorda Therapeutics
ACOR
ACOR
Delisted
ACOR was delisted on the 11th of April, 2024.
194 hedge funds and large institutions have $1.25B invested in Acorda Therapeutics in 2016 Q1 according to their latest regulatory filings, with 37 funds opening new positions, 81 increasing their positions, 56 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
86% less call options, than puts
Call options by funds: $1.28M | Put options by funds: $9.34M
Holders
194
Holding in Top 10
1
Calls
$1.28M
Puts
$9.34M
Top Buyers
| 1 | +$27.2M | |
| 2 | +$18.6M | |
| 3 | +$16.7M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$13.2M |
| 5 |
Morgan Stanley
New York
|
+$10.2M |
Top Sellers
| 1 | -$38.6M | |
| 2 | -$37.5M | |
| 3 | -$34.9M | |
| 4 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$21.4M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$16.7M |